Specifically, CCR2 on GMSC‐EVs may bind to cognate ligand CCL2, a chemokine abundantly expressed within the inflamed RA synovium and known to be a key driver of leukocyte recruitment and disease pathogenesis [1, 32, 33], leading to EVs retention in the joint tissue. Here, CCL2 is linked to rheumatoid arthritis.